Clostridium butyricum M588 (Miyarisan)

酪酸梭菌活菌（米雅利桑制药）

Report date: 2023/06/08 13:39:52

Base Information

Drug NameClostridium butyricum M588 (Miyarisan)
Drug Alias NameClostridium butyricum Miyairi 588 strainCdactin-OMIYA-BMCBM-588
ClassificationNatural product/Extract > Microbial extractBiologics > Live Biotherapeutic
Mechanisms of ActionGastrointestinal microbiome modulatorsBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsDiarrheaConstipationClostridium Infections
Global Approved IndicationsDiarrheaConstipation
Approved Indications in ChinaDiarrheaConstipation
Original Approved Country/TerritoryJapan
Original Approved Date1968/10/03
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMiyarisan Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMiyarisan Pharmaceutical Co Ltd
Inactive CompaniesOsel Inc
Active IndicationsDiarrheaConstipation
Inactive IndicationsClostridium Infections

Other Information

ATC CodeA07FA
Related LinksN/A